Approval · Notice of Compliance 16395 · 2014
ACYCLOVIR: Notice of Compliance 16395
Issued December 2, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16395
- Date
- December 2, 2014
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Update to the product monograph - removal of 200 mg and 800 mg tablets
- Therapeutic class
- Antiviral agent
- Canadian reference product
- ZOVIRAX (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACYCLOVIR | Not yet assigned | — |
Medicinal ingredients
- ACYCLOVIR 400 MG per TAB